| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 109.97B | 109.11B | 106.12B | 99.08B | 89.58B | 86.36B |
| Gross Profit | 22.30B | 23.91B | 24.47B | 21.32B | 21.56B | 22.85B |
| EBITDA | 10.08B | 12.15B | 12.19B | 10.10B | 10.13B | 10.74B |
| Net Income | 4.94B | 6.67B | 7.39B | 4.89B | 5.58B | 5.70B |
Balance Sheet | ||||||
| Total Assets | 145.78B | 146.13B | 143.86B | 127.18B | 117.56B | 112.07B |
| Cash, Cash Equivalents and Short-Term Investments | 35.89B | 41.34B | 39.87B | 34.22B | 33.45B | 29.69B |
| Total Debt | 3.33B | 3.56B | 3.49B | 3.57B | 4.12B | 4.50B |
| Total Liabilities | 52.36B | 51.67B | 52.27B | 48.07B | 42.64B | 41.75B |
| Stockholders Equity | 93.32B | 94.36B | 88.66B | 76.00B | 71.96B | 67.52B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.35B | 7.29B | 4.53B | 8.04B | 5.50B |
| Operating Cash Flow | 0.00 | 7.24B | 12.96B | 8.32B | 10.64B | 8.18B |
| Investing Cash Flow | 0.00 | -2.00B | -5.95B | -2.89B | -3.75B | -3.24B |
| Financing Cash Flow | 0.00 | -5.44B | -2.54B | -5.61B | -3.83B | -2.24B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥358.31B | 5.46 | 9.34% | 4.27% | -0.48% | -35.29% | |
79 Outperform | ¥352.81B | 14.16 | 9.59% | 3.91% | 0.87% | 16.71% | |
71 Outperform | ¥102.66B | 13.88 | ― | 2.25% | -1.95% | -1.37% | |
62 Neutral | ¥123.57B | 13.27 | ― | 3.21% | -1.68% | 1262.84% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥162.79B | 9.97 | 4.24% | 3.76% | -7.81% | 25.04% | |
57 Neutral | ¥2.57B | 10.71 | ― | 4.05% | -4.09% | 59.57% |